An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure
ACTIVE_NOT_RECRUITING
Status
Conditions
- Prevention of Venous Thromboembolism
- Congenital Heart Disease
- Fontan Procedure
- Children
Interventions
- DRUG: Rivaroxaban (Xarelto, BAY59-7939)
Sponsor
Bayer
Collaborators